<DOC>
	<DOCNO>NCT00680433</DOCNO>
	<brief_summary>Research mechanism underlie memory impairment ECT suggest development may prevent administration certain medication time ECT treatment . For example reason believe ketamine , also use anaesthetic agent , may protective property . In clinical study patient undergoing course ECT offer opportunity receive small dose ketamine ( placebo ) part anaesthetic time ECT treatment . Mood change memory change evaluate see subject receive ketamine less memory side effect , still improve depression .</brief_summary>
	<brief_title>Ketamine Anaesthetic Agent Electroconvulsive Therapy ( ECT )</brief_title>
	<detailed_description>This study report two related trial . In outpatient trial , patient administer adjunctive ketamine two different dos ( 0.25mg/kg ; 0.5mg/kg ) , placebo ( saline ) , across 3 consecutive session within regular maintenance ECT course . The order condition randomise across participant . Patients require learn word face 20 minute prior ECT , complete detail cognitive battery 4 hour ECT 3 occasion . The purpose trial determine whether ketamine superior placebo reduce cognitive impairment follow ECT optimal dose ketamine minimise cognitive side effect . Projected sample trial N = 17 . In inpatient trial , patient randomly assign receive ketamine placebo duration acute ECT course . Patients administer detailed cognitive battery day commence ECT treatment , day 6th treatment , 1-3 day 1 month follow end acute ECT course . The purpose trial examine whether patient ketamine condition superior cognitive outcome placebo condition follow course ECT . In addition , depressive symptomatology examine throughout ECT course determine whether ketamine anaesthesia ECT antidepressant , well , cognitive benefit . Projected sample trial N = 34 . This entry give detail main clinical trial : The effect ketamine across course ECT .</detailed_description>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Satisfy DSMIVTR criterion Major Depressive Episode 18 year Does diagnosis schizophrenia , schizoaffective disorder , rapid cycling bipolar disorder , current psychotic symptom No known sensitivity ketamine No ECT last 3 month No drug alcohol abuse last 12 month Able give inform consent Score least 24 Mini Mental State Examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>